News
SINT
3.600
+2.86%
0.100
Weekly Report: what happened at SINT last week (1208-1212)?
Weekly Report · 3d ago
CIO Makes Bold Move with Major Stock Purchase in Sintx Technologies
TipRanks · 12/10 02:08
Gregg R. Honigblum, Chief Investment Officer, acquires common shares of SINTX Technologies Inc
Reuters · 12/09 13:00
SINTX Technologies Inc. Chief Investment Officer Gregg R. Honigblum Acquires Common Shares
Reuters · 12/08 13:00
SiNtx Technologies Price Target Cut to $16.00/Share From $25.00 by Ascendiant Capital
Dow Jones · 12/08 10:41
SiNtx Technologies Is Maintained at Buy by Ascendiant Capital
Dow Jones · 12/08 10:41
Weekly Report: what happened at SINT last week (1201-1205)?
Weekly Report · 12/08 10:35
Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $16
Benzinga · 12/08 10:31
Sintx Technologies signs supply agreement with EVONIK
TipRanks · 12/01 13:35
SINTX Technologies Strikes Supply Agreement With Evonik To Produce Proprietary Silicon Nitride-PEEK Compound
Benzinga · 12/01 13:33
SINTX Technologies Signs Supply Agreement With Evonik for Silicon Nitride–PEEK Implant Production
Reuters · 12/01 13:30
SINTX TECHNOLOGIES SIGNS SUPPLY AGREEMENT WITH EVONIK TO MANUFACTURE SILICON NITRIDE–PEEK COMPOUND FOR AI-ASSISTED, 3D-PRINTED PATIENT-SPECIFIC IMPLANTS
Reuters · 12/01 13:30
Weekly Report: what happened at SINT last week (1124-1128)?
Weekly Report · 12/01 10:29
Weekly Report: what happened at SINT last week (1117-1121)?
Weekly Report · 11/24 10:35
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 11/21 12:05
Weekly Report: what happened at SINT last week (1110-1114)?
Weekly Report · 11/17 10:36
Sintx Technologies GAAP EPS of -$3.46 misses by $2.95, revenue of $0.21M misses by $0.09M
Seeking Alpha · 11/13 17:16
Biomaterials firm SINTX misses Q3 revenue estimates
Reuters · 11/13 13:09
SINTX Technologies Receives FDA 510(K) Clearance For Its SINAPTIC Foot & Ankle Osteotomy Wedge System
Benzinga · 11/13 13:08
SINTX Technologies posts Q3 net loss of $3.5 million on first OsseoSculpt revenue
Reuters · 11/13 13:06
More
Webull provides a variety of real-time SINT stock news. You can receive the latest news about Sintx Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About SINT
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.